Profile data is unavailable for this security.
About the company
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
- Revenue in EUR (TTM)487.56m
- Net income in EUR11.34m
- Incorporated1967
- Employees2.77k
- LocationBoiron SA2 avenue de l ouest LyonnaisRONTALON 69510FranceFRA
- Phone+33 478456100
- Fax+33 478456291
- Websitehttps://www.boiron.fr/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adcock Ingram Holdings Limited | 460.90m | 36.40m | 388.69m | 2.44k | 10.04 | 1.33 | -- | 0.8433 | 5.01 | 5.01 | 63.41 | 37.78 | 1.13 | 2.52 | 4.30 | 3,947,840.00 | 8.90 | 10.24 | 12.85 | 14.44 | 32.70 | 30.34 | 7.90 | 9.05 | 0.8498 | -- | 0.1488 | 41.41 | 5.60 | 6.38 | -9.39 | 3.37 | -9.93 | 6.58 |
| JCR Pharmaceuticals Co Ltd | 192.43m | -27.69m | 390.88m | 987.00 | -- | 1.34 | -- | 2.03 | -38.86 | -38.86 | 267.09 | 386.12 | 0.3194 | 0.5309 | 2.43 | 33,507,600.00 | -4.54 | 5.86 | -7.10 | 9.33 | 65.73 | 73.83 | -14.20 | 13.60 | 0.666 | -26.06 | 0.4466 | 45.13 | -22.86 | 5.94 | -186.42 | -- | 15.37 | 20.11 |
| Boiron SA | 487.56m | 11.34m | 394.77m | 2.77k | 34.46 | 1.03 | 8.06 | 0.8097 | 0.6529 | 0.6529 | 28.08 | 21.78 | 0.8359 | 1.30 | 5.51 | 175,950.60 | 1.94 | 4.01 | 2.44 | 5.04 | 73.58 | 73.23 | 2.32 | 5.81 | 1.61 | -- | 0.0381 | 66.42 | -1.15 | -2.63 | -68.36 | -22.53 | -15.75 | 2.71 |
| Zhejiang Cheng Yi Pharmaceutical Co Ltd | 87.10m | 19.74m | 396.10m | 738.00 | 20.07 | 2.68 | -- | 4.55 | 0.5072 | 0.5072 | 2.24 | 3.80 | 0.4013 | 2.01 | 17.68 | 992,793.70 | 9.07 | 12.01 | 11.17 | 14.75 | 66.13 | 69.79 | 22.60 | 22.84 | 1.01 | -- | 0.1998 | 36.44 | 2.54 | 4.24 | 0.8129 | 10.94 | -23.56 | 12.84 |
| Henan Taloph Pharmaceutical Stock Co Ltd | 209.89m | 3.66m | 403.20m | 2.21k | 100.58 | 2.15 | -- | 1.92 | 0.0588 | 0.0588 | 3.19 | 2.75 | 0.4892 | 3.22 | 1.73 | 797,462.90 | 0.9865 | 0.3241 | 1.97 | 0.6105 | 24.75 | 26.22 | 2.02 | 0.6331 | 0.9224 | 1.43 | 0.4197 | 52.82 | -6.21 | 8.16 | 16.00 | 2.61 | -19.14 | -- |
| Dishman Carbogen Amcis Ltd | 269.65m | 322.20k | 403.89m | 1.13k | 1,233.57 | 0.6965 | 13.68 | 1.50 | 0.21 | 0.21 | 173.66 | 371.95 | 0.277 | 0.5627 | 4.82 | -- | 0.0331 | -0.7247 | 0.0429 | -0.9005 | 81.50 | 75.60 | 0.1195 | -2.77 | 0.6755 | 1.12 | 0.2906 | -- | 3.66 | 5.82 | 102.11 | -54.07 | -11.91 | -- |
Data as of Jul 09 2025. Currency figures normalised to Boiron SA's reporting currency: Euro EUR
4.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Financi�re de l'�chiquier SAas of 31 Mar 2025 | 238.57k | 1.36% |
| HMG Finance SAas of 30 Jun 2025 | 100.05k | 0.57% |
| Dimensional Fund Advisors LPas of 04 Jul 2025 | 81.89k | 0.47% |
| DNCA Finance SAas of 31 Mar 2023 | 74.85k | 0.43% |
| HC Capital Advisors GmbHas of 31 Mar 2025 | 59.26k | 0.34% |
| Amplegest SASas of 31 Dec 2024 | 46.82k | 0.27% |
| Amiral Gestion SAas of 31 Dec 2024 | 42.16k | 0.24% |
| Sycomore Asset Management SAas of 30 May 2025 | 38.68k | 0.22% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 28.80k | 0.16% |
| Twenty First Capital SASas of 30 Jun 2023 | 21.50k | 0.12% |
More ▼
Data from 30 Jun 2024 - 04 Jul 2025Source: FactSet Research Systems Inc.
